Skip Navigation

JNCI Journal of the National Cancer Institute 2000 92(14):1116-1118; doi:10.1093/jnci/92.14.1116
© 2000 by Oxford University Press
This Article
Right arrow Full Text Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Reynolds, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Reynolds, T.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Journal of the National Cancer Institute, Vol. 92, No. 14, 1116-1118, July 19, 2000
© 2000 Oxford University Press

NEWS

Costs Studies Show Clinical Trials, Standard Therapy May Be Equal

Tom Reynolds

It is a common lament that insurers are crippling progress in cancer treatment by refusing to pay treatment costs for patients in clinical trials.

But evidence is emerging that routine care costs for trial participants may be no greater than for patients treated outside trials. And while a major federally funded study gears up to answer that question definitively, industry sources say that insurers are moving to cover routine care costs in trials, that some highly reputable insurers have long done so, and that the true barriers to improved clinical trial participation lie elsewhere.

Findings presented in May at the American Society for Clinical Oncology’s annual meeting in New Orleans suggest that routine care costs for trial participants are comparable to those for other cancer patients. One study done by the American Association of Cancer Institutes at five large cancer centers found that 6-month direct medical charges for 35 . . . [Full Text of this Article]

New Study

‘Moving in the Right Direction’

Definitions Unclear


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 JCOHome page
D. P. Goldman, M. L. Schoenbaum, A. L. Potosky, J. C. Weeks, S. H. Berry, J. J. Escarce, B. A. Weidmer, M. L. Kilgore, N. Wagle, J. L. Adams, et al.
Measuring the Incremental Cost of Clinical Cancer Research
J. Clin. Oncol., January 1, 2001; 19(1): 105 - 110.
[Abstract] [Full Text] [PDF]